Figure 1.
Cytokines and inflammatory markers are increased in serum of patients with hantavirus pulmonary syndrome (HPS). Levels of serum markers in HPS patients, sampled either at days 1–4 (n = 38), days 5–10 (n = 38), or days 11–23 (n = 17) post symptom debut, and controls (n = 29–33). Kruskal–Wallis test; median values. *P < .05; **P < .01; ***P < .001; ****P < .0001. Abbreviations: BAFF, B-cell activating factor; C5, complement factor 5; C5a, complement factor 5a; IFN-γ, interferon gamma; IL, interleukin; sCD25, soluble CD25; sTRAIL, soluble TNF-related apoptosis-inducing ligand; VEGF, vascular endothelial growth factor.